Position in VIR
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,034,001
-$663,697 QoQ
Shares Held
115,402
-59.0% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRUDENTIAL FINANCIAL INC holds $507,740,529 across 170 Biotechnology names. VIR ranks #63 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,491 | $108,548,965 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
131,560 | $58,746,801 | |
| 3 | INCY |
Incyte Corp
|
374,280 | $35,227,233 | |
| 4 | EXEL |
Exelixis, Inc.
|
463,825 | $19,893,454 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
64,133 | $12,804,153 | |
| 6 | ALMS |
Alumis Inc.
|
538,733 | $11,868,287 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
164,570 | $11,212,154 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
95,235 | $10,037,769 |
All Filings in VIR
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,034,001 | 115,402 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,697,698 | 281,542 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,440,827 | 252,334 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,076,678 | 610,452 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $4,333,752 | 668,789 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,795,136 | 244,569 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $3,186,013 | 425,369 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,590,514 | 291,069 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,445,844 | 142,729 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,682,819 | 465,489 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,924,086 | 312,069 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $5,210,515 | 212,414 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $5,097,340 | 219,052 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $6,535,598 | 258,222 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,026,623 | 260,717 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $3,724,019 | 146,212 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,637,258 | 63,657 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $451,149 | 10,775 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $276,569 | 6,355 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $228,126 | 4,825 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $234,047 | 4,565 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||